Neurocrine Bioscienc (NBIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NBIX | UTHR | SMMT | ||
| Company | Neurocrine Bioscienc | United Therapeutic | Summit Therapeu ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 150.00 | 569.17 | 17.46 | ||
| High | 154.74 | 573.52 | 18.15 | ||
| Low | 149.54 | 561.20 | 17.06 | ||
| Latest | 152.25 | 564.94 | 18.08 | ||
| Change | +2.66 | -4.24 | +0.93 | ||
| % Change | +1.78% | -0.74% | +5.42% | ||
| Volume | 1,414,900 | 628,400 | 3,878,900 | ||
| 20-Day Average Volume | 1,260,745 | 444,630 | 5,312,440 | ||
| Previous Close | 149.59 | 569.18 | 17.15 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 133.50 | 574.85 | 21.07 | ||
| 20-Day Raw Stochastic | 91.44% | 9.72% | 20.87% | ||
| 20-Day Relative Strength | 72.07 | 51.60 | 46.51 | ||
| Weighted Alpha | +30.38 | +71.42 | -5.19 | ||
| Today's Opinion | 8% Buy | 80% Buy | 8% Buy | ||
| Previous Opinion | 8% Buy | 80% Buy | 24% Sell | ||
| Last Month's Opinion | 64% Sell | 100% Buy | 8% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +15.53% since 05/01/26 | -0.96% since 05/01/26 | +12.19% since 05/01/26 | ||
| Low | 131.78 on 05/04/26 | 561.20 on 05/08/26 | 16.00 on 05/04/26 | ||
| High | 154.74 on 05/08/26 | 609.35 on 05/06/26 | 18.19 on 05/06/26 | ||
| 1-Month | |||||
| %Chg | +14.34% since 04/08/26 | -2.88% since 04/08/26 | -3.88% since 04/08/26 | ||
| Low | 125.64 on 04/13/26 | 560.16 on 04/24/26 | 15.14 on 05/01/26 | ||
| High | 154.74 on 05/08/26 | 609.35 on 05/06/26 | 29.23 on 04/21/26 | ||
| 3-Month | |||||
| %Chg | +7.83% since 02/06/26 | +16.40% since 02/06/26 | +20.61% since 02/06/26 | ||
| Low | 122.14 on 02/12/26 | 464.44 on 02/11/26 | 14.58 on 02/12/26 | ||
| High | 154.74 on 05/08/26 | 609.35 on 05/06/26 | 29.23 on 04/21/26 | ||
| 6-Month | |||||
| %Chg | -0.08% since 11/07/25 | +25.85% since 11/07/25 | -0.55% since 11/07/25 | ||
| Low | 122.14 on 02/12/26 | 445.81 on 11/10/25 | 13.83 on 02/05/26 | ||
| High | 160.18 on 12/08/25 | 609.35 on 05/06/26 | 29.23 on 04/21/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 15,308,738 | 23,980,002 | 14,033,028 | ||
| Shares Outstanding, K | 100,550 | 42,447 | 776,163 | ||
| Annual Sales | 2,860,500,000 | 3,182,700,000 | 0 | ||
| Annual Net Income | 478,600,000 | 1,334,700,000 | -1,079,590,000 | ||
| Last Quarter Sales | 805,500,000 | 790,200,000 | 0 | ||
| Last Quarter Net Income | 153,700,000 | 364,300,000 | -189,400,000 | ||
| 60-Month Beta | 0.34 | 0.60 | -1.25 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.94 on 05/05/26 | 5.82 on 05/06/26 | -0.24 on 04/30/26 | ||
| Earnings Date | 07/29/26 | 07/29/26 | 08/10/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 25.18 | 21.01 | 0.00 | ||